Angel Kings is a venture capital and angel investing group focused on early-stage to Series A–C investments primarily in biotechnology. See contact routes.
Angel Kings is a venture capital and angel investing group focused on early-stage to Series A–C investments primarily in biotechnology, drug discovery, and scientific innovation, with additional exposure to cybersecurity. The firm targets the top 1% of startups aiming for billion-dollar valuations and has supported entrepreneurs through the FDA discovery process. Notable portfolio companies include Authy, Buffer, Checkr, TuteGenomics, and Planetary Resources, with a combined portfolio valuation exceeding $3.5 billion. Their distinctive thesis centers on backing scientific breakthroughs that directly benefit patients and physicians, often participating in lengthy regulatory pathways like FDA approvals.
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to comparable investors.
Investors like Angel Kings · Full investor directory · Investor access · Company funding database